Atraz Tablet
Marketer
Feron Healthcare Pvt Ltd
Salt Composition
Anastrozole (1mg)
Overview Atraz Tablet
Atrana tablets are indicated, either independently or in conjunction with other therapies like surgery or radiotherapy, for managing early-stage breast cancer in women who have completed menopause. This medication also serves as a primary treatment option for advanced breast cancer that has metastasized within the breast or to distant sites. Atrana tablets are classified as aromatase inhibitors, reducing the body's estrogen levels. Administer with or without food, maintaining consistent daily timing for optimal efficacy. Dosage and frequency are determined by your physician based on your individual needs and condition. The physician will adjust the dosage to manage your symptoms effectively. Ingest the tablets whole with water. Continue treatment for the duration prescribed. Frequently reported adverse effects include hot flashes, nausea, skin rashes, arthralgia, osteoporosis, and fatigue. Report any bothersome or severe reactions to your doctor; management strategies may be available. Prior to initiating therapy, inform your physician if menopause has not occurred, if you have hepatic or renal impairment, or if you are currently taking other medications, as interactions may reduce efficacy or alter the drug's action. Disclose any pregnancy or breastfeeding status. Your doctor may order blood tests to assess vitamin D levels and bone mineral density.
Uses of Atraz Tablet
Malignant breast tumor
Major Benefits of Atraz Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Atraz Tablet. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Atraz Tablet can be taken with or without food, though consistent timing is recommended.
Common Side effects of Atraz Tablet:
- Hot flashes
- Nausea
- Osteoporosis
- Skin rash
- Weakness
How to use Atraz Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Atraz Tablet. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Atraz Tablet can be administered with or without food, although consistent timing is recommended.
How Atraz Tablet works:
Atraz Tablet functions as an aromatase inhibitor, reducing the body's estrogen production—a key female hormone. Consequently, the growth of certain estrogen-dependent breast cancer cells may be slowed or halted.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Atraz Tablet's interaction with alcohol is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Atraz Tablet during pregnancy is unsafe due to confirmed risks to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the hazards. Always seek medical advice.
Breast feedingUNSAFE
Lactation and Atraz Tablet are incompatible. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Taking Atraz Tablet may cause drowsiness, blurred vision, and dizziness, reducing alertness. Refrain from driving if these effects are experienced.
KidneyCAUTION
For individuals with severely impaired kidney function, Atraz Tablet requires careful administration and potential dosage modification. Consult your physician for guidance. Data regarding Atraz Tablet use in such patients is limited. Dosage changes are not typically advised for those with mildly or moderately impaired kidney function.
LiverCAUTION
Patients with liver impairment should use Atraz Tablet cautiously, as dose modification may be necessary. Consult your physician for guidance, as data on Atraz Tablet use in such patients is limited. No dose change is advised for those with mild or moderate hepatic dysfunction.
What if you forget to take Atraz Tablet :
Should you forget to take your Atraz Tablet, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Atraz Tablet
| Label | Value |
|---|---|
| Chemical Category | Phenylpropanoid |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Aromatase inhibitor |



